10x Genomics, Inc. (TXG) NASDAQ
30.71
+1.12(+3.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
30.71
+1.12(+3.79%)
Currency In USD
| Market Cap | 2.03B |
| Enterprise Value | 1.72B |
| P/E Ratio | -173.9 |
| PEG Ratio | -0.68 |
| Price/Sales Ratio | 6.1 |
| Price/Book Ratio | 4.84 |
| Enterprise/Revenue | 5.46 |
| Enterprise/EBITDA | -592.82 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.04 |
| Operating Margin | -0.06 |
| Return On Assets | -0.02 |
| Return On Equity | -0.03 |
| Revenue | 642.82M |
| Revenue/Share | 4.98 |
| Gross Profit | 443.88M |
| EBITDA | -110.89M |
| Net Income | -43.54M |
| Diluted EPS | -0.35 |
| Total Cash | 539.85M |
| Total Cash/Share | 4.21 |
| Total Debt | 81.39M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 5.9 |
| Book Value Per Share | 6.35 |
| 52-Week Change | 224.97 |
| 52-Week High | 31.15 |
| 52-Week Low | 8.95 |
| Moving Average 50 Days | 22.88 |
| Moving Average 200 Days | 18.05 |
| Average Volume | 2.57M |
| Shares Outstanding | 126.96M |
| % Held by Institutions | 98.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | July 17, 2006 |